ArticleCancer management and research2019

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.

Yanjie You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.